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Abstract 
Background: The virulence and pathogenicity of different influenza strains are responsible for a more or less severe 
disease. Recent studies have attempted to understand how host genetic factors may influence the clinical presenta-
tion of the disease. In the present study, the His131Arg (rs1801274) polymorphism was investigated in individuals 
from a Brazilian admixed population with a diagnosis of influenza A(H1N1)pdm09 infection.
Methods: In the present study, the influence of the His131Arg (rs1801274) polymorphism, a variant of the FCGR2A 
gene, was investigated in 436 patients with a diagnosis of influenza A(H1N1)pdm09, evaluated at health services in 
the northern and northeastern regions of Brazil between June 2009 and August 2010. Patients were divided into a 
group of non-hospitalized patients (n = 192) and a group of hospitalized patients (n = 244; 100 of them died).
Results: No significant difference in the allele or genotype frequencies of the rs1801274 polymorphism was 
observed between groups (p = 0.952 and p = 0.388). Multinomial logistic regression showed no effect of the 
rs1801274 polymorphism on severity or death of patients from the Brazilian admixed population (p = 0.368 and 
p = 0.469).
Conclusions: The rs1801274 polymorphism is not associated with severe disease in patients infected with influenza 
A(H1N1)pdm09.
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Background
Influenza, or the flu, is an acute respiratory tract infec-
tion caused by the influenza virus, which shows a global 
distribution and high transmissibility. In April 2009, 
the Centers for Disease Control and Prevention (CDC) 
reported two cases of influenza in children from Cali-
fornia, USA [1], caused by a new influenza strain. This 
strain originated from the genetic rearrangement of four 
other circulating viruses and resulted in the first influ-
enza pandemic in the 21st century [2]. The increase in 
severe cases and deaths among children and young adults 
called attention during the pandemic period [3], without 
the death rate exceeding annual figures [4]. The estimated 
rate of deaths caused by the 2009 pandemic influenza 
A(H1N1)pdm09 worldwide was 65  % in individuals 
aged 18–64 years [5]. In contrast, in southern Brazil, the 
median annual rate of underlying respiratory/circulatory 
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Although the virulence and pathogenicity of different 
viral strains are responsible for a more or less severe dis-
ease, recent studies have attempted to understand how 
host genetic factors may influence the clinical presentation 
of the disease, considering signaling pathways activated 
by viral infection [7], as well as pathways activated by the 
immune system in an attempt to promote viral clearance 
[8]. Recent studies have tried to identify host genetic vari-
ants that could explain severe cases of the disease: TNF [9], 
IFTM3 [10], CCR5 [11, 12], and ST3GAL1 [13].
In 2012, a case–control study was published in which 
91 patients who developed severe pneumonia caused by 
influenza A(H1N1)pdm09 were compared to 98 asympto-
matic household contacts. The results showed that 36.6 % 
of the patients with severe pneumonia were homozygous 
for allele A of the rs1801274 variant of the FCGR2A gene, 
which encodes a histidine (His) at position 131 of the pro-
tein, while only 13.2 % of the contacts who did not develop 
the disease carried this variant. The authors concluded 
that this variant of the FCGR2A gene may be related to 
greater susceptibility to severe forms of the disease [14].
FCGR is a glycoprotein that binds to the Fc region of 
immunoglobulin G, triggering immune responses such as 
pathogen phagocytosis, clearance of immune complexes, 
antigen presentation, and degranulation [15]. Five genes are 
found on chromosome 1 (FCGR2A, FCGR2B, FCGR2C, 
FCGR3A, and FCGR3B), which encode five receptors with 
low affinity for this glycoprotein. The activation or inhibi-
tion of these receptors determines the local inflammatory 
response [16]. The genetic variant of the IgG Fc receptor 
at position 131 has been associated with susceptibility to 
inflammatory and infectious diseases [17–20]. In the pre-
sent study, the His131Arg (rs1801274) polymorphism was 
investigated in individuals from a Brazilian admixed popula-
tion with a diagnosis of influenza A(H1N1)pdm09 infection.
Methods
In the present study, the His131Arg substitution in the 
FCGR2A gene (rs1801274) was studied in nasopharyngeal 
swab samples obtained from 436 subjects that were ran-
domly selected among 1524 cases from the northern and 
northeastern regions of Brazil diagnosed with influenza 
caused by strain A(H1N1)pdm09 between June 2009 and 
August 2010. Collection of the material during the study 
was accompanied by filling out a notification form of the 
Brazilian National System of Medical Care (SINAM), 
which contained the clinical data of the patient.
Viral detection was carried out at the Laboratory of 
Respiratory Viruses, virology section of the Evandro Cha-
gas Institute (Seção de Virologia do Instituto Evandro 
Chagas—SEVIR/IEC), Ananindeua, Pará, Brazil, using 
the SuperScript III™ One-Step RT-qPCR System with 
Platinum® Taq (Invitrogen Life Technologies). Using the 
same material, genomic DNA was extracted from patient 
samples with the QIAamp DNA Mini Kit (Qiagen) accord-
ing to manufacturer instructions. The extracted DNA was 
quantified in a NanoDrop spectrophotometer (Unisci-
ence®) at 260 to 280 nm and submitted to real-time PCR 
using the C__9077561_20 TaqMan® assay (Applied Bio-
systems) according to manufacturer instructions. The pro-
portions of African, European and Amerindian genetic 
ancestry of the patients were estimated using a panel of 48 
ancestry informative markers as described elsewhere [21].
The allele and genotype frequencies of the polymor-
phism studied were estimated by direct counting. The 
individual proportions of genetic ancestry were esti-
mated using the STRUCTURE  2.3.3 software [22]. Dif-
ferences in the main characteristics between the groups 
of patients were verified using the Student t test, Fisher’s 
exact test and Kruskal–Wallis test. Fisher’s exact test was 
also applied to evaluate differences in the allele and gen-
otype frequencies of the His131Arg (rs1801274) poly-
morphism between the groups of patients. Multinomial 
logistic regression controlling for age, comorbidities and 
European and African ancestry was performed to evaluate 
the existence of an association between the polymorphism 
and severity of infection. Statistical analysis was performed 
using the SPSS18.0 software, adopting a level of signifi-
cance of p < 0.05.
Ethics approval and consent to participate
All patients enrolled in the study provided their written 
informed consent. The study was approved by the Ethics 
Committee of the Center of Tropical Medicine, Federal 
University of Pará (Núcleo de Medicina Tropical, Univer-
sidade Federal do Pará).
Results
The sample of 436 subjects with the disease was divided 
into two groups (Table  1) according to disease progres-
sion: a group of non-hospitalized patients (n  =  192) 
and a group of hospitalized patients (n  =  244; 100 
of them died). The characteristics of the subjects are 
shown in Table 1. There was a predominance of women 
(62.8  %, n  =  247), with a mean age of 24.6  years. Of 
these (n = 247), 193 were of child-bearing age, 63 were 
pregnant, and 40 required hospitalization (22 died). The 
absence of comorbidities in non-hospitalized patients 
was significant (p = 0.007). Among patients with comor-
bidities (n  =  150), metabolic disorders (p  =  0.001), 
immunosuppression (p < 0.001) and obesity (p = 0.001) 
were the most frequent in severe cases of the disease.
The study of genetic ancestry in the population stud-
ied showed a median European contribution of 61.3 %, an 
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Amerindian contribution of 20.1  %, and an African con-
tribution of 13.2 %. The frequency of the homozygous AA 
genotype of the His131Arg polymorphism was 38 % in non-
hospitalized patients, 32.6  % in hospitalized patients who 
survived, and 37 % in hospitalized patients who died, with 
no significant difference among groups (p = 0.388). Mul-
tinomial logistic regression controlling for European and 
African genetic ancestry, comorbidities and age revealed 
no significant association between the FCGR2A genotypes 
and severity of the disease (hospitalization) or death of the 
patients (p = 0.368 and p = 0.469, respectively).
Discussion
A case–control study followed by a meta-analysis dem-
onstrated an increased risk of developing Kawasaki dis-
ease in carriers of allele A in the Chinese Han population 
[17]. In another meta-analysis, the His131Arg polymor-
phism in the FCGR2A gene was found to be associated 
with susceptibility to systemic lupus erythematosus and 
lupus nephritis in Asian populations [18]. This poly-
morphism was also associated with bacteremia and the 
severity of pneumonia in patients hospitalized in Spain 
[19]. In contrast, in intensive care unit patients with a 
diagnosis of invasive Streptococcus pneumoniae infec-
tion (202 with pneumonia and 55 with meningitis), the 
GG genotype (guanine) of the FCGR2A His131Arg pol-
ymorphism exerted a protective effect (OR 0.32) [20].
Although allele A of the FCGR2A gene (rs1801274) has 
recently been associated with greater susceptibility to severe 
forms of infection with influenza A(H1N1)pdm09 in the 
Mexican population in which the Amerindian contribution 
is high (approximately 60 %) [14], the present study found 
Table 1 Clinical characteristics and genotypes of patients infected with influenza A(H1N1)pmd09 virus
Age is reported as the mean ± SD, genetic ancestry is reported as the median (minimum; maximum), and all other variables are reported as absolute number (%)





Characteristics All patients Non-hospitalized Hospitalized p
Survived Died
N 436 192 144 100
Female gender 274 (62.8) 116 (60.4) 92 (63.9) 66 (66.0) 0.616a
Age (year) 24.6 ± 15.6 23.6 ± 14.3 21.4 ± 15.0 30.9 ± 17.1 <0.001b
Pregnant 63 (32.1) 23 (28.4) 18 (28.1) 22 (43.1) 0.157a
Smoking 23 (5.3) 7 (3.6) 6 (4.2) 10 (10.0) 0.081a
Abnormal chest radiograph 135 (31) 0 (0) 70 (48.6) 65 (65.0) <0.001a
Without comorbidities 286 (65.6) 52 (27.1) 53 (36.8) 45 (45.0) 0.007a
With comorbidities
 Chronic lung disorder 86 (19.7) 33 (17.2) 36 (25.0) 17 (17.0) 0.169a
 Chronic cardiovascular condition 32 (7.3) 10 (5.2) 10 (6.9) 12 (12.0) 0.110a
 Metabolic disorder 19 (4.4) 2 (1.0) 6 (4.2) 11 (11.0) 0.001a
 Immunosuppression 8 (1.8) 0 (0) 1 (0.7) 7 (7.0) <0.001a
 Obesity 9 (2.1) 1 (0.5) 1 (0.7) 7 (7.0) 0.001a
 Hemoglobinopathy 3 (0.7) 1 (0.5) 1 (0.7) 1 (1.0) 0.895a
 Chronic kidney disease 4 (0.9) 1 (0.5) 2 (1.4) 1 (1.0) 0.822a
Genetic ancestry
 Native American 0.201 (0.029;0.932) 0.186 (0.022;0.610) 0.219 (0.041;0.821) 0.213 (0.035;0.906) 0.345c
 European 0.613 (0.046;0.930) 0.638 (0.046;0.919) 0.585 (0.095;0.928) 0.578 (0.059;0.930) 0.026c
 African 0.132 (0.022;0.676) 0.125 (0.022;0.610) 0.138 (0.30;0.676) 0.149 (0.024;0.504) 0.036c
FCGR2A His131Arg (rs1801274)
 AA 157 (36.0) 73 (38.0) 47 (32.6) 37 (37.0)
 AG 195 (44.7) 80 (41.7) 74 (51.4) 41 (41.0) 0.388a
 GG 84 (19.3) 39 (20.3) 23 (16.0) 22 (22.0)
 Ad 509 (58.4) 226 (58.9) 168 (58.3) 115 (57.5) 0.952a
 Ge 363 (41.6) 158 (41.1) 120 (41.7) 85 (42.5)
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no association of this polymorphism with more severe influ-
enza infection in the Brazilian admixed population. These 
discordant results may be attributed to differences in the 
genetic composition of the populations studied.
Conclusions
The present study included a large sample and the 
symptoms of the patients were rigorously character-
ized, facts that support the results found. Some studies 
have reported an association between the His131Arg 
(rs1801274) polymorphism in the FCGRA gene and more 
severe influenza infection. Our findings demonstrate that 
the polymorphism is not associated with an unfavorable 
outcome in patients infected with influenza A(H1N1)
pdm09 in the Brazilian admixed population. Further 
studies are needed to better understand the effects of 
host genetic variants on the susceptibility to and severity 
of infections caused by influenza A(H1N1)pdm09.
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